When the Health Insurance Portability and Accountability Act, better known as HIPAA, was passed in 1996, AOL was just beginning to crawl and the iPhone was just a twinkle in Steve Jobs’ eye. But with advancing technology and changing caregiver circumstances, the question of who gets to see medical records is one that is constantly evolving.

Apps like Snapchat, where an image can be taken on a phone, sent quickly, and deleted after a certain amount of time, could bring new ways for doctors to more accurately diagnose by getting a second opinion. Updated networks such as Samsung’s proposed 5G could make diagnosis easier from remote places. And as ACOs are looking towards mobile devices for help in getting the best results in the face of the Affordable Care Act, HIPAA remains an issue as to consider.

The HIPAA Security Rule, which was finalized in 2003, states that any organization that is responsible for information has to ensure confidentiality, integrity,...

May 17th, 2013
0

A doctor fights for a lower-tech, higher-empathy approach to end-of-life care. A career con man exposes how Google AdWords helped him run an illegal online pharmacy. A look at long-term fraud at Ranbaxy, company that makes generic Lipitor for millions of Americans. An MIT study demonstrates Moore's Law isn't the best option for long-term forecasting.

 
 
How Not to Die
Harvard Medical School professor Dr. Angelo Volandes is on a quest to improve end-of-life care and reduce unwanted treatment from the equation [...
May 17th, 2013
0

A new report published by the Canadian Health Policy Institute has found that Canada's average per capita expenditure on medical devices between 2006 and 2011 was $168 far below the average per capita expenditure of its southern neighbor that stood at $318.

Still, over five years, Canada's per capita expenditure on medical devices grew nearly at the same rate as that of the U.S. It jumped 34.3 percent from $136 in 2006 to $183 five years later.

But the U.S. wasn't the country that took the top spot in terms of the five-year increase in per capital medical device expenditure. Switzerland saw its per capita expenses shoot up 55.5 percent in the same period to $445 in 2011 from $286 in 2006.

The purpose of the report, which compared Canada's data with 65 other countries, was to determine whether expenses on medical devices in Canada is to be blamed for fast-growing healthcare costs overall. The author...

May 14th, 2013
0

Could the actress's drawing attention to these procedures boost the market for devices associated with them? 

In a New York Times op-ed today, actress Angelina Jolie shared the news that she has undergone a preventive double mastectomy. Jolie, who is 37, decided to undergo the procedure after gene testing discovered she carries BRCA1, a gene that has been found to increase the risk of breast and ovarian cancer. Ovarian cancer killed Jolie's mother, Marcheline Bertrand, at the age of 56.

"My doctors estimated that I had an 87 percent risk of breast cancer and a 50 percent risk of ovarian cancer, although the risk is different in the case of each woman," Jolie writes.

In the op-ed, Jolie discusses her experience in trying to head off the disease.

On genetic testing:

Cancer is still a word that strikes fear into people...

May 14th, 2013
0

A while back we told you about one medtech outsourcing partner that's trying to become a more sustainable supplier to the industry. Mack Medical's Julie Horst said sustainable manufacturing is becoming as important as ISO certifications these days. 

If you're interested in taking steps to make your manufacturing operations more sustainable, check out these resources:

Sustainable Manufacturing Initiative’s Sustainable Business Clearinghouse
Search more than 850 federal, state, and nongovernmental resources aimed at helping U.S. businesses increase competitiveness and profitability in sustainable ways through this Web portal maintained by the U.S. Department of Commerce’s (DOC) International Trade Administration. 

...

May 13th, 2013
0

The medical device tax is decreasing the flow of funding deals in the medical device industry.

Private equity and venture capital (PE/VC) investing in the medical device industry took a hard hit in 2012. Deals decreased by 13% in value and 15% in number of transactions from 2011. The bright spot, however, was Q4 2012. According to CB Insights, a venture capital database, the medical device industry closed 68 deals in the fourth quarter of 2012, a 41% increase from the previous quarter. But is it enough to keep the industry afloat in 2013? 

The medical device industry is poised for growth as the country’s aging Baby Boomers continue to get older and need increased medical care....

May 13th, 2013
0

In a session at the 2013 American Telemedicine Association's International Meeting & Trade Show, Henley also cited five forces impacting healthcare today.  

The plenary session on Monday at the American Telemedicine Association's International Meeting & Trade Show was presented by Jeffrey Henley, chairman of Oracle Corp.

Oracle is engaged in healthcare by enabling patient-centered technology for health engagement, and the company has invested heavily in developing software and IT infrastructure for disease management and health management. Oracle is also engaged with accountable care organizations, connected health, and public/private insurance exchanges.

Henley cited five forces affecting healthcare today:

  1. Clinical innovation
     
  2. Regulatory decisions
     
  3. Competitive threats...
May 10th, 2013
1

Reed Tuckson, managing director of Tuckson Health Connections, urges telemedicine companies not to let regulatory fears stifle innovation. 

The plenary session on Tuesday, May 7, at the American Telemedicine Association's International Meeting & Trade Show was a highly energetic presentation by Reed Tuckson, MD, the current managing director of Tuckson Health Connections and former executive vice president and chief of medical affairs at United Health Group.

His talk, titled “An Insider’s Perspective: Real World Challenges and Opportunities for Telemedicine’s Full Adoption,” was to a large extent a call to arms.  He asked what we’re trying to do, as “innovation for innovation’s sake is not acceptable.”

Critical factors impacting this are cost (“CMS is done; states are broke”); the increasing prevalence of preventable chronic diseases (“one-third of people born in 2020 will...

May 10th, 2013
0

MD+DI editorial advisory board member Bill Betten shares his thoughts on the 2013 International Meeting & Trade Show of the American Telehealth Association.

As noted in my day one notes, the American Telemedicine Association show is certainly growing in both conference and exhibitor attendance. The conference proceedings included many demonstrations and discussions of telemedicine in use.

The initial stages of the technology tend to be focused on providing care to remote locations or underserved areas, much as how radiology evolved into the teleradiology we know today.

There has not yet been a transformative impact on new methods of delivering care. I do believe that this will occur in the not-too-distant future, particularly with regard to monitoring of chronic health conditions.

There was a large emphasis on the exhibition...

May 10th, 2013
0

Hospira Inc., GemStar Infusion System: Recall

Posted 4/29/13, Updated 5/1/13
Damage from battery leakage may cause the device to shut off without warning. The clinical impact of a delay and/or interruption in therapy is dependent upon the clinical condition of the patient and the product being infused. Health care professionals are advised to weigh the risks and benefits to patients before using the device to administer critical therapies. 

Newport Medical Instruments, Inc., HT70 and HT70 Plus Ventilators: Class I Recall

Initiated by company 4/4/13, Posted by FDA 5/1/13
The recall is in response to customer reports of Newport Medical Instrument’s HT70 Ventilator and...

May 10th, 2013
0